Author:
Lee Chung K.,Poortmans Philip
Publisher
Springer Berlin Heidelberg
Reference178 articles.
1. Aleman BM, Raemaekers JM, Tirelli U et al (2003a) Involved-field radiation therapy for advanced Hodgkin’s lymphoma. N Engl J Med 348(24):2396–2406
2. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, van Leeuwen FE (2003b) Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 21(18):3431–3439
3. Aleman BM, Raemaekers JM, Tomisic R et al (2007) Involved-field radiation therapy for patients in partial remission after chemotherapy for advanced Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 67(1):19–30
4. Altman DG, Royston P (2000) What do we mean by validating a prognostic model? Stat Med 19(4):453–473
5. Anagnostopoulos I, Hansmann ML, Franssila K et al (2000) European task force on lymphoma project on lymphocyte predominance Hodgkin disease: Histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96(5):1889–1899
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献